|
Natco Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
14555.36 Cr.
|
P/BV
|
1.91
|
Book Value (Rs.)
|
424.71
|
|
52 Week High/Low (Rs.)
|
1505/727
|
FV/ML
|
2/1
|
P/E(X)
|
7.72
|
|
Bookclosure
|
20/11/2025
|
EPS (Rs.)
|
105.26
|
Div Yield (%)
|
0.74
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 2291.40 | 1673.50 | 861.90 | 202.20 | 579.60 |
| | | | | | |
| Net CashFlow From Operating Activities | 1696.80 | 1211.60 | 849.10 | 46.50 | 298.80 |
| Net Cash Used In Investing Activities | -1414.50 | -1032.70 | -477.10 | -5.30 | -103.30 |
| Net Cash Used From Financing Activities | -210.70 | -246.90 | -363.00 | 34.80 | -185.70 |
| Foreign Exchange Gains / Losses | -22.00 | 6.50 | 11.80 | 9.30 | -3.80 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 49.60 | -61.50 | 20.80 | 85.30 | 6.00 |
| Cash And Cash Equivalents Begin of Year | 70.40 | 131.90 | 111.10 | 25.80 | 19.80 |
| Cash And Cash Equivalents End Of Year | 120.00 | 70.40 | 131.90 | 111.10 | 25.80 |
